top of page
Fully Synthetic Datasets.
No Real Patient Data, No Privacy Risk.
Each dataset includes:
-
4 feature types: demographics, serum labs, diagnoses, medications
-
Realistic value generation using medical literature + probabilistic modeling
-
Serum–medication interactions
-
Patient summaries and feature breakdowns
Disclaimer: These datasets are synthetic and for non-clinical use only.
Lupus
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissues and organs. It can affect the skin, joints, kidneys, brain, and other organs, leading to a wide range of symptoms that vary from person to person. Common signs include fatigue, joint pain, rashes, and inflammation. Lupus is complex, often difficult to diagnose, and currently has no cure, but treatments can help manage symptoms and improve quality of life.
Systemic Sclerosis
Systemic Sclerosis (SSc), also known as scleroderma, is a rare autoimmune disease characterized by abnormal growth of connective tissue, leading to skin thickening and internal organ involvement. It commonly affects the skin, blood vessels, lungs, heart, and digestive system. Symptoms can range from mild skin changes to serious complications like pulmonary fibrosis or hypertension. While there is no cure, early diagnosis and symptom-targeted treatments can help slow disease progression and improve daily function.
Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the lining of the large intestine (colon) and rectum. It often leads to symptoms such as abdominal pain, diarrhea, fatigue, and rectal bleeding. The condition typically develops over time and can range from mild to severe, with periods of flare-ups and remission. While there's no known cure, various medications and lifestyle changes can help manage symptoms and reduce inflammation.
Vasculitis
Vasculitis refers to a group of rare disorders that involve inflammation of the blood vessels, which can restrict blood flow and damage vital organs and tissues. It can affect vessels of any size and occur in nearly any part of the body, leading to a wide range of symptoms such as fatigue, fever, skin rashes, nerve issues, or organ dysfunction. Some forms are mild and self-limiting, while others can be severe or life-threatening. Early diagnosis and prompt treatment—often involving immunosuppressive medications—are key to managing the disease effectively.
Sjögren’s Disease
Sjögren’s Disease is a chronic autoimmune condition in which the immune system attacks the body’s moisture-producing glands, primarily affecting the eyes and mouth. Common symptoms include dry eyes, dry mouth, fatigue, and joint pain, though it can also affect organs such as the lungs, kidneys, and nervous system. It may occur on its own (primary Sjögren’s) or alongside other autoimmune diseases like lupus or rheumatoid arthritis. While there's no cure, treatments focus on relieving symptoms and preventing complications.
Dermatomyocitis
Dermatomyositis is a rare autoimmune disease that causes inflammation in the muscles and skin, leading to muscle weakness and distinctive skin rashes. It commonly affects the shoulders, hips, neck, and thighs, and may be accompanied by symptoms such as fatigue, difficulty swallowing, or lung involvement. A hallmark sign is a purplish or reddish rash, often appearing on the face, eyelids, knuckles, or chest. While the exact cause is unknown, treatment with immunosuppressive medications can help manage symptoms and improve muscle strength.
Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that primarily targets the joints, causing pain, swelling, stiffness, and progressive joint damage. Unlike osteoarthritis, RA can affect multiple joints symmetrically and may also involve the lungs, heart, eyes, and blood vessels. It often begins in middle age but can occur at any age, and symptoms may come and go in flares. Early diagnosis and treatment with disease-modifying medications are crucial to slowing progression and preserving joint function.
Crohn's Disease
Crohn’s Disease is a chronic inflammatory bowel disease (IBD) that causes inflammation anywhere along the gastrointestinal tract, most commonly in the small intestine and colon. It can lead to symptoms such as abdominal pain, diarrhea, weight loss, and fatigue, often with periods of flare-ups and remission. Unlike ulcerative colitis, Crohn’s can affect all layers of the bowel wall and occur in patches. While there's no cure, treatments like medication, dietary changes, and sometimes surgery can help control inflammation and improve quality of life.
Infection
General Infection refers to the invasion and multiplication of harmful microorganisms—such as bacteria, viruses, fungi, or parasites—within the body. Infections can be localized (affecting one area) or systemic (spreading throughout the body), and symptoms vary widely depending on the cause and location. Common signs include fever, fatigue, inflammation, and changes in organ function. While many infections are mild and treatable, others can be serious or life-threatening, especially in individuals with weakened immune systems.
Drug Induced Lupus
Drug-Induced Lupus (DIL) is a lupus-like autoimmune condition triggered by prolonged use of certain medications. It shares many symptoms with systemic lupus—such as joint pain, muscle aches, fever, and fatigue—but typically does not affect major organs like the kidneys or brain. Symptoms usually resolve once the offending medication is discontinued. Common drugs associated with DIL include certain antibiotics, anti-seizure medications, and drugs used to treat high blood pressure or heart disease.
PLEASE NOT THIS SAMPLE DATA IS STILL IN BETA.
PLEASE NOT THIS SAMPLE DATA IS STILL IN BETA.
General Population
The General Population Dataset represents a synthetic sample of individuals without known autoimmune or inflammatory diseases. It is designed to reflect a broad distribution of demographic characteristics, lab values, and health patterns typical of the general public. Most individuals in this dataset do not exhibit abnormal serum markers or clinical impressions associated with specific conditions. This dataset can be used as a baseline or control group for comparison against disease-specific cohorts.
bottom of page